Conclusion not excluding drug discount agreement. according to Section 130a Paragraph 8 SGB V through an open house model for the active ingredient Denosumab Prolia (ATC code according to WHO: M05BX04)
Tender Details
This tender document contains detailed specifications, requirements, and submission guidelines. Purchase access to view the full document including eligibility criteria, scope of work, and evaluation methodology.
The complete document includes all annexes, terms of reference, and bidding instructions required for your submission.
Contact the procuring entity directly for pre-bid inquiries and clarifications.
Unlock Full Details
Get complete tender information, documents, and contact details.
No account needed · Sent to your email
Get This Tender
Pay once, get this tender sent to your email. No account needed.
Subscribe for time-based access to multiple tenders.
No plans available right now.
Account required for subscriptions
Subscriptions require an account to manage your access and renewal.
Or without signing up
